Literature DB >> 21666729

Research technique: the murine candidate.

Elie Dolgin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21666729     DOI： 10.1038/474S14a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

Authors:  Karl-Dimiter Bissig; Stefan F Wieland; Phu Tran; Masanori Isogawa; Tam T Le; Francis V Chisari; Inder M Verma
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Hepatitis C virus replication in mice with chimeric human livers.

Authors:  D F Mercer; D E Schiller; J F Elliott; D N Douglas; C Hao; A Rinfret; W R Addison; K P Fischer; T A Churchill; J R Lakey; D L Tyrrell; N M Kneteman
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

3.  A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

Authors:  Michael L Washburn; Moses T Bility; Liguo Zhang; Grigoriy I Kovalev; Adam Buntzman; Jeffery A Frelinger; Walter Barry; Alexander Ploss; Charles M Rice; Lishan Su
Journal:  Gastroenterology       Date:  2011-01-13       Impact factor: 22.682

4.  Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C.

Authors:  Erwin Daniel Brenndörfer; Malin Weiland; Lars Frelin; Emma Derk; Gustaf Ahlén; Jian Jiao; Johannes Georg Bode; Matti Sällberg
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

5.  Elimination of hepatitis C virus by short term NS3-4A and NS5B inhibitor combination therapy in human hepatocyte chimeric mice.

Authors:  Eiji Ohara; Nobuhiko Hiraga; Michio Imamura; Eiji Iwao; Naohiro Kamiya; Ichimaro Yamada; Tomohiko Kono; Mayu Onishi; Daizaburo Hirata; Fukiko Mitsui; Tomokazu Kawaoka; Masataka Tsuge; Shoichi Takahashi; Hiromi Abe; C Nelson Hayes; Hidenori Ochi; Chise Tateno; Katsutoshi Yoshizato; Shinji Tanaka; Kazuaki Chayama
Journal:  J Hepatol       Date:  2010-10-26       Impact factor: 25.083

6.  Pathogenesis of hepatitis C virus infection in Tupaia belangeri.

Authors:  Yutaka Amako; Kyoko Tsukiyama-Kohara; Asao Katsume; Yuichi Hirata; Satoshi Sekiguchi; Yoshimi Tobita; Yukiko Hayashi; Tsunekazu Hishima; Nobuaki Funata; Hiromichi Yonekawa; Michinori Kohara
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

7.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962
  7 in total
  4 in total

Review 1.  The Strange, Expanding World of Animal Hepaciviruses.

Authors:  Alex S Hartlage; John M Cullen; Amit Kapoor
Journal:  Annu Rev Virol       Date:  2016-09-29       Impact factor: 10.431

2.  Serology-enabled discovery of genetically diverse hepaciviruses in a new host.

Authors:  Peter D Burbelo; Edward J Dubovi; Peter Simmonds; Jan L Medina; Jose A Henriquez; Nischay Mishra; Jason Wagner; Rafal Tokarz; John M Cullen; Michael J Iadarola; Charles M Rice; W Ian Lipkin; Amit Kapoor
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

3.  Identification of rodent homologs of hepatitis C virus and pegiviruses.

Authors:  Amit Kapoor; Peter Simmonds; Troels K H Scheel; Brian Hjelle; John M Cullen; Peter D Burbelo; Lokendra V Chauhan; Raja Duraisamy; Maria Sanchez Leon; Komal Jain; Kurt Jason Vandegrift; Charles H Calisher; Charles M Rice; W Ian Lipkin
Journal:  mBio       Date:  2013-04-09       Impact factor: 7.867

4.  Canine hepacivirus is not associated with chronic liver disease in dogs.

Authors:  N H Bexfield; P J Watson; J Heaney; J L Heeney; L Tiley
Journal:  J Viral Hepat       Date:  2013-08-12       Impact factor: 3.728
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.